Research
Hormonal
Retatrutide resulted in a percentage change in weight from baseline to 24 weeks ranging from -7.2% to -~18% as the dose increased from 1 mg to 12 mg.
Retatrutide may be an effective treatment option for weight loss in individuals with obesity.
StrongSupportsmedium confidence
The primary end point was percentage change in weight from baseline to 24 weeks, which ranged from -7.2% to -~18% as the dose of retatrutide increased from 1 mg to 12 mg.
Why this rating
Based on the phase 2 clinical trial design mentioned in the abstract.
Source
Retatrutide showing promise in obesity (and type 2 diabetes)
Sheila A Doggrell · Expert Opinion on Investigational Drugs · 2023
otherCited 14×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →